Showing results (2361-2370 of 6,472) with videos related to

Sort By:
Pageof 648
Open Forum Infectious Diseases|July 10, 2024
Antimicrobial Stewardship Practices in Outpatient Parenteral Antimicrobial Therapy Programs in the United StatesSara F Azimi, Esther Golnabi, Ryan P Mynatt, et al.
Open Forum Infectious Diseases|July 10, 2024
Long-acting HIV Treatments: Study Design, Logistics, and AccessNicholas A Murdock, Nayri E Alajaji, Robin Schaefer, et al.
Open Forum Infectious Diseases|July 8, 2024
Clinical Presentation and Outcomes Following Infection With Vibrio spp, Aeromonas spp, Chromobacterium violaceum, and Shewanella spp Water-Associated Organisms in Tropical Australia, 2015-2022Stuart Campbell, Kirsten MacGregor, Emma L Smith, et al.
Open Forum Infectious Diseases|July 5, 2024
Unmet Needs for Ancillary Services by Provider Type Among People With Diagnosed Human Immunodeficiency VirusCelina Thomas, Xin Yuan, Jennifer A Taussig, et al.
Open Forum Infectious Diseases|June 13, 2024
Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment-A Cross-sectional StudyLouise E van Eekeren, Nadira Vadaq, Wilhelm A J W Vos, et al.
Open Forum Infectious Diseases|June 13, 2024
Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York CityElizabeth A Garcia, Mary M K Foote, Tristan D McPherson, et al.
Open Forum Infectious Diseases|June 13, 2024
Variation in North American Infectious Disease Specialists' Practice Regarding Oral and Suppressive Antibiotics for Adult Osteoarticular Infections: Results of an Emerging Infections Network (EIN) SurveyNicolás Cortés-Penfield, Susan E Beekmann, Philip M Polgreen, et al.
Open Forum Infectious Diseases|May 15, 2024
National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US HospitalsLeo Knudsen Westgard, Taisuke Sato, William S Bradford, et al.
Open Forum Infectious Diseases|May 17, 2024
Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life UpdateVera Portillo, Silvio Ragozzino, Elisavet Stavropoulou, et al.
Open Forum Infectious Diseases|August 25, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled TrialAngela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, et al.
Pageof 648